NYK Logistics (UK) Ltd has been awarded a major contract with Ranbaxy Laboratories Limited (Ranbaxy), the global generics company of the Daiichi-Sankyo Group, a leading innovator pharmaceutical powerhouse, ranked among the top 15 in the world and headquartered in Tokyo. Ranbaxy has revenues of $1.6 billion.
NYK Logistics is handling all Ranbaxy product destined for the UK market.
The operation is based at NYK Logistics’ Pharmaceutical Centre of Excellence in Northampton, which provides supply chain solutions for a number of major pharmaceutical customers. The 175,000 sq ft facility provides temperature-controlled, high-security storage in line with the latest Good Distribution Practice.
NYK’s Healthcare Distribution Centre has a Manufacturers’ Import Authorisation from the Medicines & Healthcare Regulatory Authority (MHRA), as well as an MHRA Wholesale Dealer’s Licence. NYK is therefore able to provide storage for product manufactured in Europe, as well as imports from outside the EU.
NYK receives all Ranbaxy’s product batch released and ready for sale throughout the UK.
NYK is handling 23 million packs per annum on behalf of Ranbaxy, destined for hospitals, pharmacies and wholesalers.